Press Releases

June 20, 2012

Bethesda, MD (June 20, 2012) — The Foundation for the National Institutes of Health (FNIH), along with the NIH Fogarty International Center (FIC), is contributing to research focused on the discovery of novel dietary and microbial therapeutics that will benefit infants and children living in countries with widespread malnutrition and at risk for disease and growth deficits.

June 6, 2012

The Foundation for the National Institutes of Health (FNIH) is accepting nominations for the first Lurie Prize in the Biomedical Sciences, an annual award recognizing outstanding achievement by a young scientist in biomedical research.

June 1, 2012

The Food and Drug Administration (FDA) has drafted a regulatory guidance describing a new way of conducting breast cancer drug trials that promises to reduce substantially the time and cost of getting new treatments to patients. The approach is based on a trial design being tested in the I-SPY 2 TRIAL, an innovative Phase II breast cancer trial being conducted under the auspices of the Biomarkers Consortium, a public-private partnership led by the Foundation for the National Institutes of Health (FNIH) that includes representatives from NIH, FDA, and multiple pharmaceutical companies and academic research centers.

May 18, 2012

The Foundation for the National Institutes of Health (FNIH) announces that Burlington Coat Factory has donated $25,000 in support of The Heart Truth® Campaign.

April 25, 2012

The Foundation for the National Institutes of Health (FNIH) is awarded the coveted 4-star rating “for sound fiscal management and commitment to accountability and transparency” by Charity Navigator, the leading charity evaluator in America.

February 14, 2012

The Foundation for the National Institutes of Health (FNIH) announces the launch of a new research study designed to improve clinical outcomes for those living with osteoarthritis (OA) of the knee or who are at risk of developing the disease.

February 7, 2012

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a research collaboration that aims to remove obstacles to developing new antibacterial treatments for common, serious skin infections and community-acquired bacterial pneumonia, or CABP.

February 1, 2012

The Foundation for the National Institutes of Health (FNIH) has awarded grants totaling nearly $300,000 to six community organizations, as part of a public-private partnership with the National Heart, Lung, and Blood Institute (NHLBI) in support of The Heart Truth® Community Action Program.

January 9, 2012

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium today announced the release of biomarker data from studies intended to improve our ability to diagnose and measure the progression of Alzheimer’s disease (AD). Researchers used proteomics to identify biomarkers for Alzheimer’s disease using cerebrospinal fluid (CSF) samples provided by the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest public-private partnership to date in AD research. As with all ADNI data, these have been made openly available to the global research community.

November 8, 2011

The Foundation for the National Institutes of Health (FNIH) today announced U.S. Surgeon General, Regina M. Benjamin, MD, MBA, will deliver a keynote address on December 6th, the second day of the 2011 mHealth Summit, at 9:45 a.m.